Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods.
about
Patient Uncertainty Questionnaire-Rheumatology (PUQ-R): development and validation of a new patient-reported outcome instrument for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in a mixed methods studyQualitative interviewing as measurement.Rasch analysis of clinical outcome measures in spinal muscular atrophy.A brief 5-item version of the Neck Disability Index shows good psychometric properties.Psychometric evaluation of the Disabilities of the Arm, Shoulder and Hand (DASH) with Dupuytren's contracture: validity evidence using Rasch modelingDevelopment and validation of a condition-specific diary to measure severity, bothersomeness and impact on daily activities for patients with acute urinary tract infection in primary care.Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?Psychometric properties of four fear of falling rating scales in people with Parkinson's disease.Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing-remitting multiple sclerosis using classical and modern test theory.Knowledge deficit, attitude and behavior scales association to objective measures of sun exposure and sunburn in a Danish population based sample.Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson's disease.Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.Parents' Assessments of Disability in Their Children Using World Health Organization International Classification of Functioning, Disability and Health, Child and Youth Version Joined Body Functions and Activity Codes Related to Everyday Life.Examining the psychometric properties of a sport-related concussion survey: a Rasch measurement approachInterpretation of response categories in patient-reported rating scales: a controlled study among people with Parkinson's diseasePhysical disability, anxiety and depression in people with MS: an internet-based survey via the UK MS Register.The physical and psychological impact of multiple sclerosis using the MSIS-29 via the web portal of the UK MS Register.Home and health in people ageing with Parkinson's disease: study protocol for a prospective longitudinal cohort survey study.Using mixed methods to select optimal mode of administration for a patient-reported outcome instrument for people with pressure ulcers.Walking ability is a major contributor to fear of falling in people with Parkinson's disease: implications for rehabilitation.Rasch analysis of the Patient Rated Elbow Evaluation questionnaire.Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation ScaleThe Early Development Instrument: an evaluation of its five domains using Rasch analysis.Rasch Analysis of the Premature Ejaculation Diagnostic Tool (PEDT) and the International Index of Erectile Function (IIEF) in an Iranian Sample of Prostate Cancer Patients.Measuring Life Satisfaction in Parkinson's Disease and Healthy Controls Using the Satisfaction With Life Scale.The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patientsRasch analyses of the Activities-specific Balance Confidence Scale with individuals 50 years and older with lower-limb amputationsDevelopment and Psychometric Evaluation of the FACE-Q Scales for Patients Undergoing Rhinoplasty.Development and Psychometric Validation of the FACE-Q Skin, Lips, and Facial Rhytids Appearance Scales and Adverse Effects Checklists for Cosmetic Procedures.The BODY-Q: A Patient-Reported Outcome Instrument for Weight Loss and Body Contouring Treatments.Development and validation of a new patient-reported outcome measure for patients with pressure ulcers: the PU-QOL instrument.Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.Measuring safety climate in acute hospitals: Rasch analysis of the safety attitudes questionnaire.Is the Give Youth a Voice questionnaire an appropriate measure of teen-centred care in paediatric oncology: a Rasch measurement theory analysis.Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple SclerosisSeverity score system for progressive myelopathy: development and validation of a new clinical scale.The Effect of Community Exercise Interventions for People with MS Who Use Bilateral Support for GaitRasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy.FACE-Q Eye Module for Measuring Patient-Reported Outcomes Following Cosmetic Eye TreatmentsDanish translation and linguistic validation of the BODY-Q: a description of the process.
P2860
Q27303944-EC263A1C-1BD0-4FB8-8F2B-D370E1D9F70BQ30388487-4F87A939-32A8-48AB-8675-5EF8609AC719Q30407124-55CD8213-A5F6-4108-87B0-B023968DAC8BQ30541686-9E244897-E9DB-48C9-A530-D686FED76D3EQ30597451-377F13C0-5B52-4E79-BB07-DFAFCE28E5D2Q30842883-AC4F1ACD-8A82-4A77-8CF5-98987626DFE0Q33610149-181D9469-6E59-4C7E-9EA7-508BB1A8AD50Q33672868-4CC6F454-88D0-49C7-A97A-99BE4BE34C49Q33692762-0631399C-4BC1-42FF-A0D1-F07A4ED49328Q33728422-99F04600-3824-4075-AFF7-9610C59AC79FQ33749919-C9BCC749-7C9E-44BD-82B2-B665173B0C40Q33810138-CBA29942-FB9B-4048-B061-BD9A5F591BF3Q33828599-48F77903-420B-49BD-9BBB-4401BEA7592CQ33837140-43C2B8D3-C6BF-4986-8A59-16091456A1DAQ34013932-522507AC-B767-4D26-B4C0-F830413B03F1Q34083645-B9F42DA5-46E4-4EB5-ADB0-510AA32DC6C2Q34576550-A2BD62E0-9B8B-44A7-AC19-20416D0E2ACFQ35012559-A6317239-23DC-4A97-A93B-AFD956437DD5Q35093216-63C5F2BB-ACF2-432C-AB40-F1134FFF62FBQ35220188-5DC0045F-4C97-4E16-9FE0-79A157B1671EQ35786053-B3A40E17-DCE3-4360-B5C7-845527610F43Q35814449-814DF63E-900E-4FC8-B2E9-641A9FC4A3E5Q35899564-037E37F5-6ACF-40AF-AEED-DE747E6D3FA8Q36060010-8A4E7C8F-940D-478C-A62C-76A4177C4AB3Q36173025-D05A3DDB-00FB-45F1-8E0B-BEFBC38B7AC2Q36340989-D026083F-BFC6-4C93-9229-8F4382F34B0FQ36556844-D1F0A514-5F4B-4275-A807-30263FE2851BQ36796587-FB92DC1A-1133-4D6D-936C-F60BC2E6DD14Q36803834-D9C82CB3-6FFB-466F-BC6C-828A2DC7DF46Q36877096-823A4D89-DAE4-4F70-98B2-C75FDB45B1C7Q36972548-D1454207-B40E-458E-83BE-13E6A860D54AQ37098220-E0044C4D-4253-49B5-BE21-BB267BB9C1ECQ37267934-C431A075-8D6D-4913-9372-FAB05F3CC5A9Q37333385-2B57003A-7259-40E6-8E2E-38417DFFACB4Q37355058-1251EB9D-0ACF-4816-9C6F-C9FC82E74D23Q37371116-4C34C5EE-6D10-4D57-95BD-F5D727647CDAQ37541917-B03EEA15-DB1C-4072-BC1E-50239C14B385Q37555748-73295404-7754-4241-AC8F-A488366C1425Q37594832-C3E6CAEA-F285-4A5F-9F60-489AAEC9EBDBQ37601475-6E2E6271-7413-4137-B9E7-9D68903A5A8F
P2860
Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improving the evaluation of th ...... e of new psychometric methods.
@en
Improving the evaluation of th ...... e of new psychometric methods.
@nl
type
label
Improving the evaluation of th ...... e of new psychometric methods.
@en
Improving the evaluation of th ...... e of new psychometric methods.
@nl
prefLabel
Improving the evaluation of th ...... e of new psychometric methods.
@en
Improving the evaluation of th ...... e of new psychometric methods.
@nl
P356
P1476
Improving the evaluation of th ...... e of new psychometric methods.
@en
P304
iii, ix-x, 1-177
P356
10.3310/HTA13120
P577
2009-02-01T00:00:00Z